Aslan Pharmaceuticals Stock Z Score
ASLNDelisted Stock | USD 0.60 0.03 4.76% |
Aslan |
Aslan Pharmaceuticals Company Z Score Analysis
Aslan Pharmaceuticals' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, Aslan Pharmaceuticals has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
All Next | Launch Module |
Aslan Fundamentals
Return On Equity | -4.27 | |||
Return On Asset | -0.54 | |||
Profit Margin | (2.92) % | |||
Operating Margin | (2.91) % | |||
Current Valuation | 288.33 M | |||
Shares Outstanding | 2.83 M | |||
Shares Owned By Insiders | 0.14 % | |||
Shares Owned By Institutions | 13.21 % | |||
Number Of Shares Shorted | 306.56 K | |||
Price To Earning | (11.50) X | |||
Price To Book | 2.14 X | |||
Price To Sales | 0.94 X | |||
Revenue | 12 M | |||
Gross Profit | 79.82 M | |||
EBITDA | (43.39 M) | |||
Net Income | (44.22 M) | |||
Cash And Equivalents | 78.12 M | |||
Cash Per Share | 1.12 X | |||
Total Debt | 26.83 M | |||
Debt To Equity | 1.12 % | |||
Current Ratio | 6.97 X | |||
Book Value Per Share | (7.70) X | |||
Cash Flow From Operations | (46.36 M) | |||
Short Ratio | 1.85 X | |||
Earnings Per Share | (16.00) X | |||
Target Price | 72.0 | |||
Number Of Employees | 35 | |||
Beta | 1.4 | |||
Market Capitalization | 1.7 M | |||
Total Asset | 24.63 M | |||
Retained Earnings | (321.07 M) | |||
Working Capital | 11.02 M | |||
Current Asset | 54.61 M | |||
Current Liabilities | 5.15 M | |||
Net Asset | 24.63 M |
About Aslan Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aslan Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aslan Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aslan Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Aslan Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aslan Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aslan Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Aslan Stock
0.75 | BKRKY | Bank Rakyat | PairCorr |
0.69 | BKRKF | PT Bank Rakyat | PairCorr |
0.75 | PPERY | Bank Mandiri Persero | PairCorr |
0.69 | PPERF | Bank Mandiri Persero | PairCorr |
Moving against Aslan Stock
0.86 | DIS | Walt Disney Sell-off Trend | PairCorr |
0.85 | BAC | Bank of America Aggressive Push | PairCorr |
0.81 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
0.79 | CVX | Chevron Corp Sell-off Trend | PairCorr |
0.76 | CSCO | Cisco Systems Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Aslan Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aslan Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aslan Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aslan Pharmaceuticals to buy it.
The correlation of Aslan Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aslan Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aslan Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aslan Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Aslan Stock
If you are still planning to invest in Aslan Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aslan Pharmaceuticals' history and understand the potential risks before investing.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |